- Report
- May 2025
- 50 Pages
Global
From €2420EUR$2,650USD£2,054GBP
Dilazep is a class of cardiovascular drugs used to treat angina, chest pain, and other heart-related conditions. It works by inhibiting the enzyme phosphodiesterase, which helps to reduce the amount of calcium in the heart muscle. This helps to reduce the amount of oxygen needed by the heart, thus reducing the risk of angina and other heart-related conditions. Dilazep is usually taken orally, but can also be administered intravenously. It is often used in combination with other drugs, such as beta-blockers, to treat angina and other heart-related conditions.
The Dilazep market is composed of a variety of pharmaceutical companies, including Pfizer, Merck, and Novartis. These companies produce and market Dilazep, as well as other cardiovascular drugs. Additionally, there are a number of generic drug manufacturers that produce and market generic versions of Dilazep. These generic versions are often cheaper than the brand-name versions, making them a popular choice for those looking to save money on their medications. Show Less Read more